Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2i+DPP4i combinations

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2i+DPP4i combinations

Saturday, May 30th 2026 - 1:30 PM (IST)

5 days to go

213 doctors attending

Saturday, May 30th 2026 - 1:30 PM (IST)

Medflix

About this session

This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.

Faculty

Key details

Registration

Free

Duration

60 min

Replay

Yes

Certificate

No

Language

English

Supported by

Supported By

Explore other sessions

Goitre in Adults: A Simple Clinical Approach

Goitre in Adults: A Simple Clinical Approach

25 May 2026 | 3:30 PM (IST)